Patent ID: 11945842
Assignee: INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY (ICGEB)
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  Y | IPC A  C

Claim 1:
2. The bio-nanoparticle of claim 1, wherein the EDIII domains are fused sequentially, N-terminal end to C-terminal end, wherein DENY-1 is fused to DENV-3, DENV-3 is fused to DENV-4, and DENV-4 is fused to DENV-2, and wherein the amino acid sequence of the EDIII domains of each of Dengue virus serotypes DENY-1, DENV-2, DENV-3, and DENV-4 is SEQ ID NO: 1, 2, 3, and 4, respectively.